AlphaMark Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.31M | Buy |
17,740
+201
| +1% | +$14.9K | 0.57% | 39 |
|
|
2024
Q3 | $1.16M | Sell |
17,539
-1,191
| -6% | -$78.6K | 0.4% | 46 |
|
|
2024
Q2 | $1.73M | Buy |
+18,730
| New | +$1.73M | 0.6% | 31 |
|
|
2023
Q4 | – | Sell |
-21,381
| Closed | -$1.48M | – | 736 |
|
|
2023
Q3 | $1.48M | Buy |
+21,381
| New | +$1.48M | 0.63% | 33 |
|
|
2023
Q2 | – | Sell |
-26,935
| Closed | -$2.23M | – | 627 |
|
|
2023
Q1 | $2.23M | Buy |
26,935
+717
| +3% | +$59.3K | 1% | 24 |
|
|
2022
Q4 | $1.96M | Buy |
+26,218
| New | +$1.96M | 0.98% | 25 |
|
|
2022
Q3 | – | Sell |
-60
| Closed | -$6K | – | 702 |
|
|
2022
Q2 | $6K | Buy |
+60
| New | +$6K | ﹤0.01% | 448 |
|
|
2021
Q3 | – | Sell |
-60
| Closed | -$6K | – | 586 |
|
|
2021
Q2 | $6K | Hold |
60
| – | – | ﹤0.01% | 440 |
|
|
2021
Q1 | $5K | Sell |
60
-50
| -45% | -$4.17K | ﹤0.01% | 436 |
|
|
2020
Q4 | $10K | Buy |
+110
| New | +$10K | ﹤0.01% | 362 |
|
|
2020
Q2 | – | Sell |
-150
| Closed | -$9K | – | 564 |
|
|
2020
Q1 | $9K | Buy |
+150
| New | +$9K | 0.01% | 308 |
|
|
2019
Q3 | – | Sell |
-120
| Closed | -$7K | – | 492 |
|
|
2019
Q2 | $7K | Hold |
120
| – | – | ﹤0.01% | 369 |
|
|
2019
Q1 | $8K | Sell |
120
-510
| -81% | -$34K | ﹤0.01% | 343 |
|
|
2018
Q4 | $32K | Buy |
630
+465
| +282% | +$23.6K | 0.02% | 214 |
|
|
2018
Q3 | $10K | Hold |
165
| – | – | ﹤0.01% | 341 |
|
|
2018
Q2 | $8K | Hold |
165
| – | – | ﹤0.01% | 384 |
|
|
2018
Q1 | $8K | Buy |
+165
| New | +$8K | ﹤0.01% | 364 |
|